BJP holds state-wide hartal protesting killing of party activist

Bengaluru, July 14: Girls outshone boys in the Second Pre-University Board examinations in Karnataka, results of which were announced on Tuesday.

As many as 6.75 lakh students had written the examination of which 4.17 lakh students passed.

Thus, the pass percentage is 61.80 per cent, Primary and Secondary Education Minister S Suresh Kumar said while announcing the results.

He said 68.73 per cent girls cleared the exam against the boys whose pass percentage was 54.77 per cent.

In terms of urban versus rural, 62.60 per cent students passed in the urban area while 58.99 per cent were from rural areas.

The three districts where the students' performance was excellent were Udupi, Dakshina Kannada and Kodagu whereas the districts where students fared badly were Chitradurga, Raichur and Vijayapura, the minister said.

Both Dakshina Kannada and Udupi have recorded 90.71 percent results. Kodagu has bagged second position with 81.53 pass percentage. Vijayapura district has recorded lowest pass percentage (54.22)

Combination wise, the pass percentage of students in science stream is 82.57 per cent, Commerce 72.60 per cent and Arts 47.90 per cent, said the Minister.

He also said of those who passed the examination, 72. 45 per cent were from English medium and 47.56 from Kannada medium.

There are 68,866 distinction scorers, 2,21,866 students who got first division and 77,455 students who passed the exam in second division, the minister added.

Ballari, Jul 17: An MLA from Karnataka’s Ballari district has tested positive for covid-19. P T Parameshwar Naik, Congress MLA from Huvina Hadagali constituency confirmed that he contracted coronavirus.

Parameshwar Naik had developed symptoms a few days back. He was subjected to Covid-19 test at a hospital in Harapanahalli. On Thursday, his report came positive. Naik’s house at Harapanahalli has been sealed. He is undergoing treatment at a hospital in Bengaluru.

The other legislators from the state to test positive for coronavirus are: MLAs C T Ravi (Chikkmagaluru), Bharat Shetty (Mangaluru North), Ranganath (Kunigal), Sharath Bachegowda (Hoskote), Rajkumar Patil Telkur (Sedam), Ajay Singh (Jewargi), Prasad Abbayya (Hubballi-Dharwad East), MLCs Bhojegowda and M K Pranesh.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.